In a recent development, experts have emphasized the importance of keeping states informed about clinical trials in India. The experts have highlighted the significance of transparency and communication between the central government and state governments when it comes to conducting clinical trials. It is crucial for states to be aware of the trials being conducted within their jurisdiction to ensure proper oversight and monitoring. The experts have also stressed the need for a robust regulatory framework to govern clinical trials in the country. India has emerged as a hub for clinical research due to its diverse population and skilled healthcare professionals. However, there have been concerns raised in the past regarding the ethical conduct of clinical trials in the country. By keeping states informed about ongoing trials and involving them in the process, the regulatory authorities can ensure that the rights and safety of participants are protected. Additionally, transparency in clinical trials can help build trust among the public and promote the growth of the pharmaceutical and healthcare sectors in India. It is essential for all stakeholders, including the central and state governments, regulatory bodies, pharmaceutical companies, and healthcare professionals, to work together to create a conducive environment for conducting ethical and transparent clinical trials in the country. By fostering collaboration and communication, India can further strengthen its position as a leading destination for clinical research.